SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-003503
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:30
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_i10q-033122.htm   iXBRL 10-Q 445961
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 10067
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 10210
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4931
  Complete submission text file 0001683168-22-003503.txt   2204878

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20220331.xsd EX-101.SCH 20293
6 XBRL CALCULATION FILE xbio-20220331_cal.xml EX-101.CAL 25268
7 XBRL DEFINITION FILE xbio-20220331_def.xml EX-101.DEF 103974
8 XBRL LABEL FILE xbio-20220331_lab.xml EX-101.LAB 159745
9 XBRL PRESENTATION FILE xbio-20220331_pre.xml EX-101.PRE 133370
39 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-033122_htm.xml XML 200682
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 22917775
SIC: 2834 Pharmaceutical Preparations